Tobacco Use, Insulin Resistance, and Risk of Type 2 Diabetes: Results from the Multi-Ethnic Study of Atherosclerosis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 Jun 21

PMID 27322410

Citations 19

Authors

Rachel J Keith

Mahmoud Al Rifai

Christopher Carruba

Natasha De Jarnett

John W McEvoy

Aruni Bhatnagar

Michael J Blaha

Andrew P DeFilippis

Affiliations

Soon will be listed here.

Abstract

Introduction: Tobacco use is associated with insulin resistance and incident diabetes. Given the racial/ethnic differences in smoking patterns and incident type 2 diabetes our objective was to evaluate the association between tobacco use and insulin resistance (IR) as well as incident type 2 diabetes mellitus in a contemporary multiethnic cohort.

Methods And Results: We studied 5,931 Multi- Ethnic Study of Atherosclerosis (MESA) participants who at baseline were free of type 2 diabetes (fasting glucose ≥7.0 mmol/l (126 mg/dl) and/or use of insulin or oral hypoglycemic medications) categorized by self-reported tobacco status and reclassified by urinary cotinine (available in 58% of participants) as never, current or former tobacco users. The association between tobacco use, IR (fasting plasma glucose, insulin, and the homeostatic model assessment of insulin resistance (HOMA-IR)) and incident diabetes over 10 years was evaluated using multivariable linear regression and Cox proportional hazards models, respectively. Mean age of the participants was 62 (±10) years, 46% were male, 41% Caucasian, 12% Chinese, 26% African American and 21% Hispanic/Latino. IR biomarkers did not significantly differ between current, former, and never cigarette users (P >0.10) but showed limited unadjusted differences for users of cigar, pipe and smokeless tobacco (All P <0.05). Fully adjusted models showed no association between dose or intensity of tobacco exposure and any index of IR. When stratified into participants that quit smoking vs. those who continued smoking during the 10-year study there was no difference in serum glucose levels or frequency of diabetes. In fully adjusted models, there was no significant difference in diabetes risk between former or current cigarette smokers compared to never smokers [HR (95% CI) 1.02 (0.77,1.37) and 0.81 (0.52,1.26) respectively].

Conclusion: In a contemporary multi-ethnic cohort, there was no independent association between tobacco use and IR or incident type 2 diabetes. The role smoking plays in causing diabetes may be more complicated than originally thought and warrants more in-depth large contemporary multi-ethnic studies.

Citing Articles

Determinants of diabetes self-care activities in patients with type 2 diabetes based on self-determination theory.

Okati-Aliabad H, Nazri-Panjaki A, Mohammadi M, Nejabat E, Ansari-Moghaddam A Acta Diabetol. 2023; 61(3):297-307.

PMID: 37855999 DOI: 10.1007/s00592-023-02186-w.

Association of smoking and dietary polycyclic aromatic hydrocarbon exposure on the prevalence of metabolic syndrome in Korean adults.

Zhang J, Tan L, Jung H, Jung J, Lee J, Lee G J Expo Sci Environ Epidemiol. 2023; 33(5):831-839.

PMID: 37019984 DOI: 10.1038/s41370-023-00541-1.

Incidence of diabetes and its predictors in the Greater Beirut Area: a five-year longitudinal study.

Nasrallah M, Elbejjani M, Nasreddine L, Chami H, Ismaeel H, Fleifel M Diabetol Metab Syndr. 2022; 14(1):67.

PMID: 35509100 PMC: 9066987. DOI: 10.1186/s13098-022-00833-w.

Smokeless Tobacco Use and Prevalence of Cardiovascular Disease Among Males in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1-4.

Nahhas G, Cummings K, Halenar M, Sharma E, Alberg A, Hatuskami D Prev Med Rep. 2022; 25:101650.

PMID: 35127346 PMC: 8800067. DOI: 10.1016/j.pmedr.2021.101650.

Central Australian Aboriginal women's pregnancy, labour and birth outcomes following maternal smokeless tobacco (pituri) use, cigarette use or no-tobacco use: a prospective cohort study.

Ratsch A, Bogossian F, Steadman K BMC Public Health. 2021; 21(1):814.

PMID: 33910555 PMC: 8082654. DOI: 10.1186/s12889-021-10872-z.

References

Soulimane S, Simon D, Herman W, Lange C, Lee C, Colagiuri S . HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis. Diabetologia. 2013; 57(1):30-9. PMC: 4240946. DOI: 10.1007/s00125-013-3058-y. View

Barrett-Connor E, Khaw K . Cigarette smoking and increased central adiposity. Ann Intern Med. 1989; 111(10):783-7. DOI: 10.7326/0003-4819-111-10-783. View

Dhar P . Measuring tobacco smoke exposure: quantifying nicotine/cotinine concentration in biological samples by colorimetry, chromatography and immunoassay methods. J Pharm Biomed Anal. 2004; 35(1):155-68. DOI: 10.1016/j.jpba.2004.01.009. View

Stepanov I, Jensen J, Hatsukami D, Hecht S . New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res. 2008; 10(12):1773-82. PMC: 2892835. DOI: 10.1080/14622200802443544. View

Ostenson C, Hilding A, Grill V, Efendic S . High consumption of smokeless tobacco ("snus") predicts increased risk of type 2 diabetes in a 10-year prospective study of middle-aged Swedish men. Scand J Public Health. 2012; 40(8):730-7. DOI: 10.1177/1403494812459814. View

Montori V, Smieja M, Guyatt G . Publication bias: a brief review for clinicians. Mayo Clin Proc. 2000; 75(12):1284-8. DOI: 10.4065/75.12.1284. View

Fukami T, Nakajima M, Yamanaka H, Fukushima Y, McLeod H, Yokoi T . A novel duplication type of CYP2A6 gene in African-American population. Drug Metab Dispos. 2007; 35(4):515-20. DOI: 10.1124/dmd.106.013557. View

Pan A, Wang Y, Talaei M, Hu F, Wu T . Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015; 3(12):958-67. PMC: 4656094. DOI: 10.1016/S2213-8587(15)00316-2. View

Haffner S, DAgostino R, Saad M, Rewers M, Mykkanen L, SELBY J . Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes. 1996; 45(6):742-8. DOI: 10.2337/diab.45.6.742. View

10.

Cugati S, Wang J, Rochtchina E, Mitchell P . Ten-year incidence of diabetes in older Australians: the Blue Mountains Eye Study. Med J Aust. 2007; 186(3):131-5. DOI: 10.5694/j.1326-5377.2007.tb00836.x. View

11.

Benowitz N . Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect. 1999; 107 Suppl 2:349-55. PMC: 1566286. DOI: 10.1289/ehp.99107s2349. View

12.

Nakajima M, Fukami T, Yamanaka H, Higashi E, Sakai H, Yoshida R . Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. Clin Pharmacol Ther. 2006; 80(3):282-97. DOI: 10.1016/j.clpt.2006.05.012. View

13.

Twig G, Afek A, Derazne E, Tzur D, Cukierman-Yaffe T, Gerstein H . Diabetes risk among overweight and obese metabolically healthy young adults. Diabetes Care. 2014; 37(11):2989-95. DOI: 10.2337/dc14-0869. View

14.

Axelsson T, Jansson P, Smith U, Eliasson B . Nicotine infusion acutely impairs insulin sensitivity in type 2 diabetic patients but not in healthy subjects. J Intern Med. 2001; 249(6):539-44. DOI: 10.1046/j.1365-2796.2001.00840.x. View

15.

Mickens L, Ameringer K, Brightman M, Leventhal A . Epidemiology, determinants, and consequences of cigarette smoking in African American women: an integrative review. Addict Behav. 2010; 35(5):383-91. PMC: 2830391. DOI: 10.1016/j.addbeh.2009.12.014. View

16.

Wannamethee S, Lowe G, Shaper A, Rumley A, Lennon L, Whincup P . Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J. 2005; 26(17):1765-73. DOI: 10.1093/eurheartj/ehi183. View

17.

Seet R, Loke W, Khoo C, Chew S, Chong W, Quek A . Acute effects of cigarette smoking on insulin resistance and arterial stiffness in young adults. Atherosclerosis. 2012; 224(1):195-200. DOI: 10.1016/j.atherosclerosis.2012.06.060. View

18.

Wang L, Rundek T, Beecham A, Hudson B, Blanton S, Zhao H . Genome-wide interaction study identifies RCBTB1 as a modifier for smoking effect on carotid intima-media thickness. Arterioscler Thromb Vasc Biol. 2013; 34(1):219-25. PMC: 4380266. DOI: 10.1161/ATVBAHA.113.302706. View

19.

McEvoy J, Nasir K, DeFilippis A, Lima J, Bluemke D, Hundley W . Relationship of cigarette smoking with inflammation and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2015; 35(4):1002-10. PMC: 4484586. DOI: 10.1161/ATVBAHA.114.304960. View

20.

Eliasson B . Cigarette smoking and diabetes. Prog Cardiovasc Dis. 2003; 45(5):405-13. DOI: 10.1053/pcad.2003.00103. View